19th Oct 2009 12:52
TR-1 |
||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
UTD Drug Plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||||
An event changing the breakdown of voting rights |
||||
Other (please specify): |
Confirmation of Current Position |
X |
||
3. Full name of person(s) subject to the notification obligation: iii |
M&G Investment Funds 3 |
|||
4. Full name of shareholder(s) (if different from 3.):iv |
Nortrust Nominee Ltd A/C MKK01 |
|||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
||||
6. Date on which issuer notified: |
16 October 2009 |
|||
7. Threshold(s) that is/are crossed or reached: vi, vii |
5% |
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
IE0033024807 |
12,000,000 |
12,000,000 |
12,000,000 |
12,000,000 |
5.08% |
|||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration date xvii |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to |
% of voting rights xix, xx |
|||||||||||
Nominal |
Delta |
|||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
12,000,000 |
5.08% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||||||
Proxy Voting: |
||||||
10. Name of the proxy holder: |
N/A |
|||||
11. Number of voting rights proxy holder will cease to hold: |
N/A |
|||||
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
|||||
13. Additional information: |
With reference to item 3, M&G Investments Funds 3 is an Open Ended Investment Company (OEIC) and is not a Prudential group company and must be separately disclosed. This OEIC Fund is managed by M&G Investment Management Limited (a wholly owned subsidiary of Prudential plc) and will have been previously attributed to Prudential plc solely on the basis that M&G Investment Management Ltd has direct fund management control over the shares identified in this notification. Therefore the 5.08% holding being disclosed in this notification is encompassed in the 6.22 % already disclosed under The Prudential plc group of companies and is NOT in addition to it. Calculations based on a Total Voting Rights figure of 236,237,527. |
|||||
14. Contact name: |
Dipesh Varsani / Mark Thomas M&G Investment Management Limited |
|||||
15. Contact telephone number: |
020 7548 3261 / 020 7548 3266 |
|||||
TR1 |
||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
UTD Drug Plc |
|||||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||||
An acquisition or disposal of voting rights |
||||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||||||
An event changing the breakdown of voting rights |
||||||
Other (please specify): |
Confirmation of Current Position |
X |
||||
3. Full name of person(s) subject to the notification obligation: iii |
Prudential plc group of companies |
|||||
4. Full name of shareholder(s) (if different from 3.):iv |
See attached schedule |
|||||
5. Date of the transaction and date on which the threshold is crossed or reached: v |
||||||
6. Date on which issuer notified: |
16 October 2009 |
|||||
7. Threshold(s) that is/are crossed or reached: vi, vii |
6% |
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction |
||||||||||||||
Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
IE0033024807 |
14,697,539 |
14,697,539 |
14,697,539 |
14,697,539 |
6.22% |
|||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial instrument |
Exercise price |
Expiration date xvii |
Exercise/ Conversion period xviii |
Number of voting rights instrument refers to |
% of voting rights xix, xx |
|||||||||||
Nominal |
Delta |
|||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
14,697,539 |
6.22% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
Prudential plc (parent Company) M&G Group Limited (wholly owned subsidiary of Prudential plc) M&G Limited (wholly owned subsidiary of M&G Group Limited) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) M&G Securities Limited (wholly owned subsidiary of M&G Limited) |
||
Proxy Voting: |
||
10. Name of the proxy holder: |
N/A |
|
11. Number of voting rights proxy holder will cease to hold: |
N/A |
|
12. Date on which proxy holder will cease to hold voting rights: |
N/A |
|
13. Additional information: |
Calculations based on a Total Voting Rights figure of 236,237,527 |
|
14. Contact name: |
Dipesh Varsani / Mark Thomas M&G Investment Management Limited |
|
15. Contact telephone number: |
020 7548 3261 / 020 7548 3266 |
This announcement has been issued through the Companies Announcement Service of
The Irish Stock Exchange.
Related Shares:
UDG.L